Deal Closes Near Target
0.0%
The most likely outcome is that Isomorphic Labs completes the financing broadly in line with the reported terms. Investor demand for AI-enabled drug discovery remains strong after AlphaFold’s scientific validation and Isomorphic’s prior large partnerships.
What it moves
- Healthcare+0.3%
- Technology+0.2%
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.